1712 Carey Ave. Ste 200 Cheyenne, WY 82002
Phone: 307-634-9636     Fax: 307-634-6335     bop@wyo.gov

Mission Statement 

The mission of the Wyoming State Board of Pharmacy is to promote and protect the health and safety of the public by regulating the practice of pharmacy.

Current News & Information

IMPORTANT NOTICE

City Drug in Evanston Wyoming and City Drug of Bridger Valley in Mountain View Wyoming are not subject to current disciplinary proceedings by the Wyoming State Board of Pharmacy.

2025 Renewals for Pharmacists and Pharmacy Technicians are now Open

For 2025 license renewals:

As a reminder, separate immunization and/or preceptor registrations are no longer required.

For more information on CE requirements, please refer to the Wyoming Pharmacy Rules  Chapter 6 Continuing Professional Education Regulations.

Alerts & Other Information

A Reminder that PREP Act Declaration for COVID-19 Countermeasures were extended through December 2024

PREP Act immunity from liability was extended by HHS through through the final day of the applicable Declaration of Emergency, or December 2024 to pharmacists, pharmacy interns, and pharmacy technicians to administer COVID-19 and seasonal influenza vaccines (to those individuals three and over, consistent with other requirements), and COVID-19 tests, regardless of any USG agreement or emergency declaration. For additional information:

REMINDER ALERT

Healthcare Distribution Alliance Pharmaceutical Cargo Security Coalition Fraud Alert

The Board's September 2022 newsletter had an article on the Healthcare Distribution Alliance Pharmaceutical Cargo Security Coalition's fraud alert that outlines some new methodologies that are being used to divert both small and large drug shipments. These schemes may involve the impersonation of regulatory personnel, including individuals from state boards of pharmacy and departments of health. They may also involve the impersonation of pharmacy or distributor staff. 

Last week a pharmacy in Casper reported being contacted by a scammer posing as the Wyoming Board of Pharmacy, who tried to obtain their wholesale distributor account number. In 2022, a pharmacy in Rock Springs, WY, reported being contacted by a scammer posing as their distributor, who said that they had shipped product to the pharmacy in error and requested that the shipment be returned.

More information is available from the National Association of Boards of Pharmacy®. If you experience an attempt at this type of scam, please email cforsaith@hda.org so that it can be shared with law enforcement.

ALERT Phishing Scam

The Board office has received reports that pharmacists are receiving calls that appear to come from the Board office’s main phone number and that the caller identifies himself or herself as an agent with the Board. The caller is able to confirm some of the pharmacist’s information, such as license number, National Provider Identifier number, and place of employment.

In some cases, the caller accuses the pharmacist of having committed a violation, that his or her license may be suspended or revoked, and that the pharmacist will be arrested if he or she does not answer the caller’s questions. In some cases, the caller alleges that the pharmacist was involved in prescription drug trafficking. Some pharmacists have reported that the caller becomes aggressive and demanding, threatening to have the Federal Bureau of Investigation come and arrest the pharmacist if he or she does not comply. 

The Wyoming State Board of Pharmacy will not contact or interact with you in this manner.

The Federal Trade Commission has useful consumer information on how to recognize and avoid phishing scams available at https://www.consumer.ftc.gov/articles/how-recognize-and-avoid-phishing-scams. If you receive such a phone call, please call and report it to the Federal Communications Commission at 888/225- 5322.

DEA Warns Healthcare Workers of Impersonation Scam Targeting Doctors and Pharmacists

The Drug Enforcement Administration (DEA) issued a critical alert to healthcare professionals, warning of recent scam calls targeting doctors and pharmacists. Fraudsters are impersonating DEA agents to steal sensitive information and possibly extort money. 

DEA personnel will never contact medical practitioners or members of the public by telephone to request personal or sensitive information, demand money or any other form of payment. Legitimate DEA agents will only notify individuals of investigations or legal actions in person or via official letter.

Reported scam tactics continually change but often share many of the same characteristics. Callers use names found online of well-known DEA officials, retired or former Special Agents, and/or police officers in local departments. Callers will also provide fake badge numbers. Additionally, they may:

Protecting Against Identity Theft

The best deterrence against these bad actors is awareness and caution. Anyone receiving a call from a person claiming to be with DEA should report the incident to the FBI at www.ic3.gov.  The Federal Trade Commission provides recovery steps, shares information with more than 3,000 law enforcement agencies and takes reports at reportfraud.ftc.gov.  

Reporting these scam calls will help federal authorities find, arrest, and stop the criminals engaged in this fraud. Impersonating a federal agent is a violation of federal law, punishable by up to three years in prison; aggravated identity theft carries a mandatory minimum sentence of two years in prison plus fines and restitution.  

The DEA is committed to protecting healthcare professionals from these fraudulent schemes. By raising awareness and encouraging prompt reporting, we can help to stop these criminals and ensure the safety and security of our nation's healthcare workforce.

ALERT Fraudulent Prescription SCAM

The Board has received alerts from pharmacies that an individual or group of individuals are calling in prescriptions for Azithromycin, Ibuprofen, and Promethazine with Codeine.  Most of the calls have allegedly come from practitioners in Washington. In some instances, they are asking for particular manufacturers of Promethazine with Codeine, attempting to call multiple sets of prescriptions in at one time, and have requested the pharmacy to ship into another state.  The Board urges pharmacists to be cautious and to utilize their professional judgment when exercising their corresponding responsibility and to carefully evaluate such prescriptions for validity before dispensing.